| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/01/2023 | Ciarimboli Dina | General Counsel and Secretary | Grant | Common Stock | 575k | $0.00 | $0 | | 07/01/2023 |
| 01/01/2023 | AH Equity Partners LSV I, L.L.C. | 10% Owner | Grant | Earn-out Shares | 12.6k | $0.00 | $0 | By AH Bio Fund II, L.P. | 01/01/2023 |
| 01/01/2023 | AH Equity Partners LSV I, L.L.C. | 10% Owner | Grant | Earn-out Shares | 13.8k | $0.00 | $0 | By AH Bio Fund III, L.P. | 01/01/2023 |
| 01/01/2023 | AH Equity Partners LSV I, L.L.C. | 10% Owner | Grant | Earn-out Shares | 8.2k | $0.00 | $0 | By Andreessen Horowitz LSV Fund I, L.P. | 01/01/2023 |
| 01/01/2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Grant | Earn-out Shares | 12.6k | $0.00 | $0 | By AH Bio Fund II, L.P. | 01/01/2023 |
| 01/01/2023 | GIUSTI KATHRYN E | Director | Grant | Earn-out Shares | 114 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Horning Sandra | Director | Grant | Earn-out Shares | 565 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Hedrick Eric | Chief Physician Executive | Grant | Earn-out Shares | 543 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Casdin Eli | 10% Owner | Grant | Earn-out Shares | 18.2k | $0.00 | $0 | By Casdin Partners Master Fund L.P. | 01/01/2023 |
| 01/01/2023 | Casdin Eli | 10% Owner | Grant | Earn-out Shares | 2.8k | $0.00 | $0 | By Casdin Venture Opportunities Fund, L.P. | 01/01/2023 |
| 01/01/2023 | Casdin Eli | 10% Owner | Grant | Earn-out Shares | 4k | $0.00 | $0 | By Casdin Private Growth Equity Fund, L.P. | 01/01/2023 |
| 01/01/2023 | Nallicheri Melanie | CEO | Grant | Earn-out Shares | 5.5k | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Nallicheri Melanie | CEO | Grant | Earn-out Shares | 2.8k | $0.00 | $0 | By MIN 2020 LLC | 01/01/2023 |
| 01/01/2023 | Borisy Alexis | Executive Chairman | Grant | Earn-out Shares | 15.1k | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | BERNS PAUL L | Director | Grant | Earn-out Shares | 453 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Conde Jorge | Director | Grant | Earn-out Shares | 12.6k | $0.00 | $0 | By AH Bio Fund II, L.P. | 01/01/2023 |
| 01/01/2023 | Conde Jorge | Director | Grant | Earn-out Shares | 13.8k | $0.00 | $0 | By AH Bio Fund III, L.P. | 01/01/2023 |
| 01/01/2023 | Conde Jorge | Director | Grant | Earn-out Shares | 8.2k | $0.00 | $0 | By Andreessen Horowitz LSV Fund I, L.P. | 01/01/2023 |
| 01/01/2023 | Ciarimboli Dina | General Counsel and Secretary | Grant | Earn-out Shares | 226 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Rubin Jami | CFO | Grant | Earn-out Shares | 1.6k | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | MEANWELL CLIVE | Director | Grant | Earn-out Shares | 226 | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Grant | Earn-out Shares | 13.8k | $0.00 | $0 | By AH Bio Fund III, L.P. | 01/01/2023 |
| 01/01/2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Grant | Earn-out Shares | 8.2k | $0.00 | $0 | By Andreessen Horowitz LSV Fund I, L.P. | 01/01/2023 |
| 09/30/2022 | Yeshwant Krishna | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | GIUSTI KATHRYN E | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | Casdin Eli | 10% Owner | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | MEANWELL CLIVE | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | BERNS PAUL L | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | Abernethy Amy | Director | Grant | Stock Option (Right to Buy) | 0 | $0.00 | $0 | | 09/30/2022 |
| 09/30/2022 | MERKSAMER SAMUEL J. | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | Abernethy Amy | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/30/2022 | Horning Sandra | Director | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 02/25/2022 | Ciarimboli Dina | General Counsel and Secretary | Grant | Stock Option (Right to Buy) | 575k | $3.03 | $1.7M | | 02/25/2022 |
| 02/25/2022 | Abernethy Amy | Director | Grant | Stock Option (Right to Buy) | 389.2k | $3.03 | $1.2M | | 02/25/2022 |
| 02/25/2022 | Hedrick Eric | Chief Physician Executive | Grant | Stock Option (Right to Buy) | 505.1k | $3.03 | $1.5M | | 02/25/2022 |
|